Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E)

INTRODUCTION: Current standard treatment for patients with early rectal cancer is radical surgical resection. Although radical surgery provides effective local tumour control, it also increases the mortality risk and considerable adverse effects, including bowel, bladder, sexual dysfunction and loss...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yajie, Wang, Yaqi, Zhang, Hui, Wan, Juefeng, Shen, Lijun, Wang, Yan, Zhou, Menglong, Wu, Ruiyan, Yang, Wang, Zhou, Shujuan, Cai, Sanjun, Li, Xinxiang, Zhang, Zhen, Xia, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565143/
https://www.ncbi.nlm.nih.gov/pubmed/37802608
http://dx.doi.org/10.1136/bmjopen-2023-076048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565143/
https://www.ncbi.nlm.nih.gov/pubmed/37802608
http://dx.doi.org/10.1136/bmjopen-2023-076048

Ejemplares similares